Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Raffaele Colombo
Oct 9, 2024, 16:51 |
Career
Raffaele Colombo: Honored to be named one of the 2024 PharmaVoice 100
Raffaele Colombo shared about being named one of the 2024 PharmaVoice 100. Read his post…
Oct 4, 2024, 17:28 |
Blog
Raffaele Colombo: sBLA for T-DXd has been accepted by FDA HER2-low or HER2-ultralow breast cancer
Raffaele Colombo shared a post on X: "sBLA for trastuzumab deruxtecan (T-DXd) has been accepted…
Sep 25, 2024, 16:28 |
Opinion
Raffaele Colombo: TROPION-Breast01 results did not achieve statistical significance
Raffaele Colombo shared on X: “Datopotamab deruxtecan (Dato-DXd) in TROPION-Breast01 did not achieve statistical significance…
Jul 18, 2024, 09:52 |
Insight
Raffaele Colombo: Trastuzumab rezetecan in patients with HER2-mutant NSCLC
Raffaele Colombo shared a post on X about a recent paper by Shun Lu et…
Jul 15, 2024, 08:52 |
Blog
Raffaele Colombo: Tisotumab vedotin as 2nd or 3rd line therapy for recurrent cervical cancer
Raffaele Colombo shared a post on X about recent paper by Ignace Vergote et al.…
Jul 1, 2024, 07:57 |
Blog
Raffaele Colombo: TOPO1i ADC after TOPO1i ADC?
Raffaele Colombo shared on X: "TOPO1i ADC after TOPO1i ADC? ADC-LOW: a French, multicentric, retrospective study…
May 26, 2024, 10:23 |
Insight
Raffaele Colombo: We always learn a lot from the publications of “unsuccessful” trials
Raffaele Colombo shared on X/Twitter: "We always learn a lot from the publications of 'unsuccessful' trials.…
May 13, 2024, 14:12 |
Blog
Raffaele Colombo: Personal selection of 30 new ADCs that will be presented at ASCO24
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on X: "Personal selection of…
Apr 8, 2024, 15:15 |
Blog
Raffaele Colombo: AACR Annual Meeting 2024 has started!
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on LinkedIn: "AACR Annual Meeting…
Mar 21, 2024, 17:13 |
Blog
Raffaele Colombo: It was such an honor and a pleasure to open the DAVA Oncology Think Tank on Antibody Drug Conjugates and Bispecifics meeting in Victoria
Raffaele Colombo, Principal Scientist and Group Lead, Medicinal Chemistry at Zymeworks Inc., recently posted on…
1
2
3
4
All:
31
Posts:
1 - 10
Inside OncoDaily Party Barcelona
Zainab Shinkafi-Bagudu has been elected as UICC President-Elect 2024-2026
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Victor Ambros and Gary Ruvkun Awarded 2024 Nobel Prize in Medicine for MicroRNA Discovery
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube